VRAX — Virax Biolabs Group Ltd
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1885827 ·
Last close
$2.39
Market Cap
$1.91M
52W High
$21.75
52W Low
$2.14
ADV30
659,320
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | 8,324,772 | 6,438,909 | 989,832 |
| Sep 2025 | — | — | — | — | 5,715,015 | 3,345,464 | 641,516 |
| Mar 2025 | — | — | — | — | 6,426,903 | 4,228,944 | 964,750 |
| Sep 2024 | — | — | — | — | 9,442,944 | 7,285,991 | 1,026,067 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-29,612,994
Inventory
$0
Receivables
$27,112
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$12,423
EBITDA
$-6,048,149
Free Cash Flow
$-3,477,016
Enterprise Value
$-4,799,707
Total Cash
$6,518,205
Total Debt
$414,387
Shares Out
796,988
Trailing EPS
$-12.64
Book Value
$13.08
ROE
-78.6%
ROA
-54.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 12,423 | -6,399,730 | -5,023,750 | 8,324,772 | 989,832 | 7,577,341 | -4,621,892 |
| Mar 2025 | 6,331 | -6,076,802 | -6,061,247 | 6,426,903 | 964,750 | 5,696,120 | -4,563,576 |
| Mar 2024 | 156,419 | -6,135,325 | -6,733,537 | 5,483,969 | 345,194 | 5,366,757 | -6,396,922 |
| Mar 2023 | 8,561 | -5,732,761 | -5,457,494 | 9,812,416 | 908,401 | 9,126,414 | -4,179,767 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-6.00
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CBIH | Cannabis Bioscience International Holdings, Inc. | $1.16M | $0.00 | — |
| ISPC | iSpecimen Inc. | $3.17M | $1.26 | — |
| BUDZ | WEED, INC. | $4.45M | $0.03 | — |
| BIAF | bioAffinity Technologies, Inc. | $4.76M | $7.93 | — |
| VNRX | VOLITIONRX LTD | $4.91M | $0.26 | — |
News headlines (Yahoo Finance, 1h cache)
Join Virax's Live Investor Webinar: Advancing Immune Diagnostics, Clinical Development and Commercial Execution
2026-08-20 14:00 · Yahoo
Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
2026-08-07 13:00 · Yahoo
Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
2026-07-20 13:00 · Yahoo
Virax Biolabs enters immune profiling product supply deal with Fosun
2026-07-13 09:48 · Yahoo
Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
2026-07-10 20:05 · Yahoo
Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
2026-07-09 17:35 · Yahoo
Why Did Virax Biolabs Stock Triple In One Session?
2026-07-09 14:31 · Yahoo
Virax Biolabs Shares Double After Exclusive Fosun Distribution Agreement (VRAX)
2026-07-09 14:06 · Yahoo
Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation
2026-06-24 13:00 · Yahoo
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
2026-05-26 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.